InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,706.58
(
-0.29%
)
Post# of 1450
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

steeledge

Send PM Follow Ignore
Followers 77
Posts 3440
Boards Moderated 0
Alias Born 02/11/2004

steeledge

Member Level

Re: None

Monday, 02/27/2017 8:36:36 AM

Monday, February 27, 2017 8:36:36 AM

Post# of 1450
MTNB uplist:
Matinas BioPharma Holdings, Inc. (OTCQB:MTNB), a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications, announced today that its common stock has been approved for listing on the NYSE MKT. The Companys common stock is expected to begin trading on NYSE MKT under the symbol MTNB beginning on March 2, 2017 . The Companys common stock will continue to trade on the OTCQB until the close of the market on March 1, 2017 .

Solid DD combined with timeliness and conviction is a recipe for profits.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up